AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Senores Pharma files SEBI Regulation 74(5) Certificate for Q3 FY26

Senores Pharmaceuticals Limited

AI Sentiment Analysis

January 12, 2026, 12:23 PM

Top Queries to Ask About Senores Pharmaceuticals Limited

Thinking to buy or sell Senores Pharmaceuticals Limited? Ask AI before you act.

Users

Trusted by 5,000+ users

More Details on This News

Senores Pharmaceuticals Limited has submitted a certificate pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. This certificate was received from MUFG Intime India Private Limited (formerly Link Intime India Private Limited), the company's Registrar and Share Transfer Agent.

The certificate pertains to the quarter ended December 31, 2025. It confirms that the securities received from depository participants for dematerialization during the quarter were confirmed (accepted/rejected) and subsequently listed on the stock exchanges where the company's earlier securities are listed. MUFG Intime India also confirmed that the security certificates received for dematerialization were mutated and cancelled after due verification by the depository participant, with the names of the depositories substituted in the register of members within the prescribed timelines.

The company has requested that this information be taken on record.

More News on Senores Pharmaceuticals Limited

Analyze Senores Pharmaceuticals Limited

Discover more trending news on Prysm

View All